Executive Director, Global Commercial Precision Medicine & Companion Diagnostics
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the SVP, Global Commercial Development, this leadership role will serve as the Global Commercial Lead for Precision Medicine & Companion Diagnostics, responsible for defining, developing, and executing the global commercial precision medicine strategy across the Revolution Medicines portfolio. This individual will ensure companion diagnostics, biomarker strategies, patient identification, and testing solutions are fully integrated into therapeutic development, launch planning, and commercializatio
